Multipronged approach attacks breast cancer cells, blocking the growth of cancer-supporting blood vessels, stimulating antitumor immune response

A unique nanoscale drug that can carry a variety of weapons and sneak into cancer cells to break them down from the inside has a new component: a protein that stimulates the immune system to attack HER2-positive breast cancer cells. The research team developing the drug - led by scientists at the Nanomedicine Research Center, part of the Maxine Dunitz Neurosurgical Institute in the Department of Neurosurgery at Cedars-Sinai Medical Center - conducted the study in laboratory mice with implanted human breast cancer cells...

Source: http://feedproxy.google.com/~r/mnt/healthnews/~3/XAO9xwEJfpk/264680.php

sport sport medical sport news